Educational draft · awaiting clinical reviewThe full textbook explains uncertainty but does not replace live national or local guidance, specialist advice, or current prescribing information.
Parkinsonism and mobility deterioration
Medicine of older adults · UK scope · Sources checked 27 Aug 2026 · Clinical review pending
!
Abrupt immobility or dopaminergic withdrawal
Sudden focal weakness, severe dysphagia, aspiration, recurrent falls, autonomic collapse or fever and rigidity after missed Parkinson's medicines may indicate stroke, fracture, sepsis or parkinsonism-hyperpyrexia syndrome.
Action: Use ABCDE and glucose, assess injury, neurology, swallowing, infection and retention, restore time-critical dopaminergic treatment by a safe route with specialist pharmacy or Parkinson's advice, and treat hyperpyrexia or respiratory compromise urgently.
Overview
Recognise Parkinsonian syndromes and acute mobility decline, preserve exact time-critical dopaminergic therapy, identify infection, injury, delirium and adverse medicines, and restore transfers, swallowing and community function through specialist multidisciplinary care.
Describe the movement syndrome and trajectory. Ask slowness, reduced dexterity, tremor, stiffness, freezing, turning, falls, voice, swallowing, sleep, smell, constipation, urinary and postural symptoms. Establish stable walking, transfers and exact Parkinson's regimen before acute change. Early falls, vertical gaze difficulty, severe autonomic failure or rapid progression suggests an atypical syndrome and merits movement-disorder review.
During sudden decline, use ABCDE and glucose and search for stroke, fracture, infection, hypoxia, pain, dehydration, constipation, retention and medicine toxicity. Obtain collateral because delirium and hypophonia obscure history. Examine focal neurology, injuries, chest, abdomen, bladder, hydration and lying-standing blood pressure. Do not explain fever and rigidity as severe Parkinson's without checking medication interruption and systemic complications.
Practice
Two practice questions
Your practice draft is saved in this browser.
Question 1 of 2
0 correct
Medicine of older adultsOriginal SBA
Missed Parkinson's medicines
A hospitalised patient with Parkinson's disease becomes profoundly rigid and unable to swallow after several levodopa doses were omitted. What is the best immediate response?
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources
Sources and review status
National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 27 Aug 2026; clinical approval remains outstanding.
Reconcile medicines to the minute. Record levodopa preparation, strength, number of tablets, modified or immediate release, dispersible products, dopamine agonist, MAO-B or COMT inhibitor, amantadine, apomorphine and device therapy. Ask actual home administration times and relation to meals. Convert these into time-critical inpatient orders and ensure stock and trained administration are available.
Delayed or omitted doses cause off periods, rigidity, swallowing failure, falls and distress. Abrupt withdrawal can cause parkinsonism-hyperpyrexia syndrome with severe rigidity, fever, autonomic instability, reduced consciousness and raised CK. Treat as an emergency with restoration of dopaminergic therapy by an appropriate route, fluids and complication management under specialist advice.
If swallowing becomes unsafe, do not crush or omit blindly. Speech and language therapy assesses intake; pharmacy and the Parkinson's team calculate a temporary route from the actual levodopa-equivalent regimen. Options can include dispersible co-beneldopa through an appropriate enteral route or transdermal rotigotine bridging, but conversion is individual and can provoke delirium, hypotension or dyskinesia.
Review medicines that worsen Parkinsonism or cognition. Metoclopramide, prochlorperazine and many antipsychotics block dopamine and can cause severe motor deterioration. Seek safer antiemetic and psychosis advice. Anticholinergics, benzodiazepines, opioids and bladder medicines worsen cognition, bowel and falls. Do not remove necessary dopaminergic treatment reflexively for hallucinations before treating delirium and obtaining specialist input.
Assess motor response in relation to dose. Wearing-off occurs predictably before the next dose; delayed-on can relate to constipation or meal timing; dyskinesia may mark peak exposure; freezing can be on or off and responds variably. A diary helps specialists adjust fractionation, adjuncts or advanced therapy. Complex changes should be made by Parkinson's expertise because improving one state can worsen another.
Physiotherapy uses external visual or auditory cueing, large-amplitude movement, turning and transfer strategies, strength, balance and endurance. OT assesses dressing, bed, chair, toilet, kitchen, handwriting and medication devices. Speech and language therapy treats voice and swallow; dietetics addresses weight and protein timing without compromising nutrition. Exercise should be progressive and tied to meaningful activity.
Treat non-motor constraints. Measure orthostatic pressure and review hydration, salt and medicines within heart and kidney safety. Establish a proactive bowel routine because constipation affects comfort and levodopa absorption. Address nocturia, sleep disorder, depression, pain and drooling. Restore glasses and hearing aids to reduce delirium and freezing in unfamiliar environments.
Hallucinations require a hierarchy: assess delirium, infection, vision, sleep and medicines; ask distress, insight and risk. If Parkinson's medicines require reduction or an antipsychotic is considered, obtain specialist advice. Some antipsychotics markedly worsen motor function, and cholinesterase treatment or specialist-selected agents have condition-specific roles.
Plan transitions around exact timing, route and supply. Document mobility in on and off states, falls, aid, swallowing, cognition, posture and carers. Ensure community pharmacy can supply uncommon formulations and the care setting can administer exact times. Discuss driving and advance-care planning as disease progresses, while supporting preferences and avoiding automatic loss of autonomy.
Key points
Parkinsonism requires bradykinesia plus rigidity, rest tremor or postural instability; tremor alone does not establish Parkinson's disease.
A rapid mobility decline is not usual progression: assess missed doses, infection, constipation, retention, dehydration, pain, injury, stroke, posture and new medicines.
First-line inpatient safety is exact reconciliation of drug, formulation and individual administration times rather than standard ward-round times.
Never stop levodopa or other dopaminergic treatment abruptly; missed therapy can cause profound akinesia, aspiration and parkinsonism-hyperpyrexia syndrome.
If oral swallowing is unsafe, obtain same-day Parkinson's and pharmacy advice for dispersible, enteral, transdermal or infusion bridging based on the established regimen.
Avoid dopamine-blocking antiemetics and antipsychotics such as metoclopramide, prochlorperazine and haloperidol unless specialist circumstances clearly justify them.
Assess wearing-off, dyskinesia and freezing against dose and meal timing before interpreting a single corridor examination.
First-line rehabilitation uses Parkinson's-specific physiotherapy for cueing, amplitude, turning, strength and falls, with OT and speech and language support.
Aetiology
01
Idiopathic Parkinson's disease
Progressive nigrostriatal degeneration causes bradykinesia with rigidity, rest tremor and later postural, cognitive and autonomic features.
02
Atypical neurodegenerative parkinsonism
Multiple-system atrophy, progressive supranuclear palsy, corticobasal and Lewy-body disorders add early autonomic, gaze, cortical or cognitive signs.
03
Secondary parkinsonism
Dopamine-blocking medicines, vascular disease, hydrocephalus and structural disorders produce Parkinsonian movement through different mechanisms that require cause-specific treatment.
04
Acute reversible deterioration
Missed doses, infection, constipation, retention, dehydration, pain, sleep disruption and unsuitable medicines abruptly worsen established mobility.
Pathophysiology
1
Dopamine-network failure
Loss of nigrostriatal dopamine impairs automatic movement scaling and initiation, producing slowness, rigidity and reduced amplitude.
2
Motor fluctuation
Narrowing levodopa response and delayed gastric transit create wearing-off and unpredictable on-off periods tied to dose timing.
3
Postural and gait network involvement
Axial degeneration and impaired anticipatory adjustment cause freezing, short steps, turning instability and falls that respond variably to levodopa.
4
Non-motor system involvement
Autonomic, sleep, cognitive, mood and bulbar degeneration contributes to hypotension, hallucination, constipation and aspiration alongside motor decline.
5
Withdrawal physiology
Abrupt dopaminergic interruption can cause profound akinesia, rigidity, hyperthermia and systemic complications resembling neuroleptic malignant syndrome.
Clinical features and red flags
Idiopathic Parkinsonian pattern
Asymmetric bradykinesia, rigidity and rest tremor with sustained levodopa response supports Parkinson's disease.
Wearing-off pattern
Mobility predictably worsens before the next dose and improves after treatment takes effect.
Freezing of gait
Feet feel stuck during initiation, turning, doorways or divided attention despite the intention to walk.
Atypical syndrome clues
Early falls, gaze palsy, severe autonomic failure, pyramidal signs or poor response prompts specialist reassessment.
Abrupt immobility with delirium, pain, focal signs or hypoxia indicates a new medical process.
Red flags requiring action
New unilateral weakness, speech change or abrupt ataxia requires emergency stroke assessment rather than Parkinson's attribution.
Fever, severe rigidity, reduced consciousness and autonomic instability after missed levodopa suggests parkinsonism-hyperpyrexia syndrome
Investigations
01Timed medication and motor historyFirst step
Why
Relate deterioration to treatment exposure.
Interpretation and limitations
Record exact preparation, administration, meals, off periods, dyskinesia and missed doses using person, carer and pharmacy sources.
02Focused neurological and gait examination
Why
Confirm Parkinsonism and identify acute focal disease.
Interpretation and limitations
Assess bradykinesia, rigidity, tremor, eye movements, power, coordination, posture, freezing and response to cueing in a known dose state.
03Acute illness and injury screen
Why
Find reversible precipitants of sudden mobility deterioration.
Interpretation and limitations
Use glucose, observations, infection, renal, electrolyte, CK, imaging and bladder or bowel tests according to phenotype and red flags.
04Swallowing and nutrition assessment
Why
Define aspiration and safe medicine route.
Interpretation and limitations
Speech and language and dietetic review assesses textures, cough, weight, meal fatigue and whether enteral or bridging treatment is needed.
05Lying and standing blood pressure
Why
Identify orthostatic limitation and treatment effect.
Differential diagnosis
01
Drug-induced parkinsonism
Antipsychotics, metoclopramide and other dopamine blockers often cause more symmetric bradykinesia and require indication and withdrawal-risk review.
02
Vascular or frontal gait disorder
Lower-body gait difficulty with vascular, cognitive or urinary features may have less classic upper-limb response to dopaminergic treatment.
03
Essential tremor
Action and postural tremor without convincing bradykinesia or rigidity differs from Parkinson's disease and follows a separate assessment pathway.
04
Acute illness or injury
Stroke, fracture, infection, hypoxia, constipation, retention and dehydration explain rapid decline superimposed on Parkinsonism and require urgent treatment.
05
Atypical Parkinsonian syndrome
Early falls, gaze palsy, severe autonomic failure, pyramidal signs or poor levodopa response prompts specialist diagnostic review.
Management
01First-line acute mobility routeRestore timing and find the new causeFirst stepFirst lineA person with Parkinsonism becomes suddenly slower, rigid or unable to transfer.+
1Use ABCDE and glucose and assess stroke, injury, infection, pain, retention, loading, dehydration and orthostatic physiology.
2Reconcile exact dopaminergic drugs, formulations and personal times and restore safe administration urgently.
3Treat the precipitant and begin swallowing, delirium, pressure and mobility support while monitoring return toward baseline.
02Unsafe oral routeBridge time-critical treatment safelyDysphagia, nil-by-mouth status or reduced consciousness prevents usual tablets.+
1Obtain urgent speech and language, pharmacy and Parkinson's specialist assessment and identify the actual daily regimen.
Complications
01
Falls and fracture
Freezing, turning difficulty, postural hypotension and dyskinesia cause recurrent injury, fear-related deconditioning and loss of independent mobility.
02
Dysphagia and aspiration
Impaired oral and pharyngeal coordination causes weight loss, pneumonia and unsafe medicine administration during progressive or acute disease.
03
Delirium, hallucination and dementia
Disease, dopaminergic exposure, infection and sensory impairment interact to produce distress, unsafe behaviour and complex care decisions.
04
Autonomic and bowel dysfunction
Orthostatic hypotension, retention, urgency and constipation affect mobility, medicine absorption and night-time falls during routine self-care.
05
Akinesia and pressure injury
Missed treatment and immobility cause pain, thrombosis, pressure damage, respiratory secretion and rapid functional loss during an admission.
Monitoring and follow-up
Audit that every dopaminergic dose is administered at the person's prescribed time and correct formulation.
Track on and off mobility, freezing, dyskinesia, falls, transfers and response to cueing.
Review swallowing, cough, weight, hydration and chest infection after any route or function change.
Measure postural symptoms and blood pressure after dopaminergic, antihypertensive or hydration adjustments.
Monitor hallucination, cognition, sleep, mood and delirium precipitants without relying on one clinic snapshot.
Review bowel and bladder function because retention and constipation destabilise movement and medicine absorption.
Confirm exact supply, timing, rescue contacts and trained administration at every transition.
Special situations
Ward time is not Parkinson's time
Administration must follow the person's motor schedule rather than convenient standard medication rounds.
Off can look catastrophic
A missed dose can produce profound immobility, but new focal or systemic disease must still be excluded.
Protein timing is individual
Dietary protein can affect levodopa response, but restriction can worsen malnutrition and needs specialist dietetic planning.
Freezing needs context practice
A cue that works in a corridor may fail at the bathroom doorway or during a rushed turn.
Psychosis treatment can impair movement
Dopamine blockade may create severe rigidity, aspiration and falls in a person with Parkinsonism.
Common pitfalls
01
Calling sudden immobility normal Parkinson's progression.
02
Scheduling levodopa at standard ward times instead of personal prescription times.
03
Stopping dopaminergic medicines abruptly during nil-by-mouth care.
04
Crushing modified-release Parkinson's products without pharmacy advice.
05
Giving metoclopramide, prochlorperazine or haloperidol without recognising motor risk.
06
Adjusting complex levodopa regimens from a single off-state examination.
07
Treating hallucinations before assessing delirium, vision, infection and retention.
08
Discharging without confirmed formulation supply and timed administration capacity.
Measure lying-standing blood pressure and review antihypertensive and dopaminergic contributors while balancing motor control and syncope risk.
Driving, cognition, swallowing, bone health, continence, carer strain and advance-care planning belong in ongoing specialist follow-up.
.
Choking, wet voice, weak cough, weight loss or recurrent chest infection requires urgent swallowing and aspiration assessment.
Painful inability to weight bear after a fall requires occult fracture precautions and imaging.
Syncope, marked orthostatic hypotension or sudden palpitations requires cardiovascular and medication review before mobility progression.
New hallucinations or delirium requires infection, medicines, pain, retention and metabolic assessment before antipsychotic treatment.
Interpretation and limitations
Record pulse and symptoms with timed readings and relate findings to hydration, meals, antihypertensives and dopaminergic doses.
06Cognition, hallucination and mood assessment
Why
Characterise non-motor disease and delirium.
Interpretation and limitations
Use collateral and accessible assessment, separating acute fluctuation from chronic cognitive, sleep and psychiatric symptoms.
07Specialist diagnostic imaging
Why
Investigate uncertain or atypical Parkinsonism.
Interpretation and limitations
Structural imaging or dopaminergic imaging answers selected differential questions and does not replace clinical longitudinal diagnosis.
2
Use an individually calculated dispersible, enteral, transdermal or advanced-therapy bridge without crushing unsuitable products.
3Monitor rigidity, dyskinesia, hallucination, posture and swallow and return to the established route as soon as safe.
03Falls and freezing routeTrain movement in the dose contextFreezing, turning or postural instability limits mobility after acute danger is treated.+
1Assess gait in on and off states, posture, vision, cognition, footwear, aid and the real task where freezing occurs.
2Use Parkinson's-specific cueing, amplitude, turning, balance and progressive strength with OT home-task adaptation.
3Review dose fluctuations and orthostatic or sedative contributors with specialists and track falls and participation.
04Hallucination and cognition routeTreat causes without worsening movementHallucinations, agitation or cognitive decline affects safety or care.+
2Use communication and environmental measures and seek Parkinson's expertise before reducing dopaminergic therapy or prescribing antipsychotic treatment.
3Monitor distress, insight, motor function, swallowing, posture and carer burden and review capacity and support.